Data Beats Capital: Why the Real Challenger in Pharma IP Is the One Who Knows More
Pharma IP has a new kind of gravityand it isnt just Big Capital.
For years, the public storyline has been simple: the firm with the deepest pockets wins the patent fight. More lawyers, more expert declarations, more time. More leverage.
But the real ba…
Data Beats Capital: Why the Real Challenger in Pharma IP Is the One Who Knows More Read Post »
